ClinicalTrials.gg
RecruitingNCT06929598ShiQoLUpdated Sep 29, 2026

Shiatsu for Chronic Non-Inflammatory Pain in Children and Adolescents

An interventional study of Shiatsu Therapy in Chronic Pain, Chronic Pain Syndrome and Chronic Pain and Comorbid Emotional Problems, sponsored by Tel Aviv University. Recruiting at 2 sites in Israel. Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Tel Aviv University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started May 2025; still recruiting 1 year 6 months later.
Updated Sep 29, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Not applicable
Ages
10 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 26 studies in Chronic Pain with a site in Israel — 7 open to participants now, 7 under way, none of them phase 3. Chronic Pain · Israel.

Planned enrollment
10th of 16
40 · median 88
Started
2025
with 1 other
No phase
14 of 26
3 open now
Registered
22nd of 26
by date

Among the 26 studies in Chronic Pain with a site in Israel, this one is the 10th largest by planned enrollment of the 16 interventional ones that give a count, is one of 2 that started in 2025, is one of 14 with no phase, and was the 22nd registered.

Chronic Pain

3,228 studies on the registry are indexed under Chronic Pain; 729 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

7 of the 26 studies in Chronic Pain with a site in Israel are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in Israel have not opened yet or have stopped. Only those recruiting at a site in Israel →

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 10 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Chronic Pain with a site in Israel, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn if adding Shiatsu therapy to standard treatment can improve quality of life in children and adolescents with chronic pain that is not caused by inflammation. The main question it aims to answer is: Does Shiatsu therapy help improve the quality of life in children with long-lasting pain?

All participants will continue their regular treatment and will also:

  • Receive a 30-minute Shiatsu session once a week for six weeks
  • Complete questionnaires about their quality of life and family impact before, during, and after the treatment period

The study includes about 40 participants between the ages of 10 and 18, who are already being followed at the pediatric pain and rheumatology clinics at Tel Aviv Sourasky Medical Center.

03

Conditions studied

  • Chronic Pain
  • Chronic Pain Syndrome
  • Chronic Pain and Comorbid Emotional Problems
  • Chronic Pain, Psychogenic
  • Chronic Pain, Widespread
  • Fibromyalgia
  • Fibromyalgia Syndrome
  • Functional Pain

Keywords

  • Shiatsu
  • Complementary and Integrative Medicine
  • Pediatric Chronic Pain
  • Non-inflammatory Pain
  • Quality of Life
  • PedsQL
  • Adolescent Pain
  • Manual Therapy
  • Mind-Body Therapy
  • Pediatric Rheumatology
  • Integrative Medicine
  • Functional Pain
  • Pain Management
04

Who can participate

Ages eligible
10 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children and adolescents aged 10-18 years
  • Diagnosed with non-inflammatory chronic pain syndromes
  • Actively followed by the Pediatric Rheumatology and/or Pediatric Pain Clinics at Tel Aviv Sourasky Medical Center (at least twice a year)
  • signed by at least one legal guardian (or both guardians in cases of separated parents)
  • If participant is 16 years or older, they must also sign the informed consent

Exclusion criteria

Exclusion Criteria:

  • cannot be obtained from the participant or their legal guardians
  • Legal guardians unable to provide informed consent
  • Patients with severe conditions (e.g., bone )
  • Patients unable to participate in Shiatsu therapy sessions
  • Participation in Shiatsu therapy within 6 months prior to study enrollment
  • Participant or legal guardian refuses participation
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Shiatsu Therapy Group

    Participants will receive 30-minute Shiatsu therapy sessions once a week for 6 weeks, in addition to their usual pain management. The goal is to assess whether Shiatsu improves quality of life in children and adolescents with non-inflammatory chronic pain.

    Behavioral: Shiatsu Therapy

Interventions

  • BehavioralShiatsu Therapy

    Participants will receive one 30-minute session of Shiatsu therapy per week for 6 weeks. Therapy will be provided by trained Shiatsu practitioners under a standardized protocol developed for this study.

06

What researchers measure

Primary outcomes

  1. Change in Pediatric Quality of Life Inventory Version 4.0 (PedsQL 4.0) Generic Core Scale Total Score

    The PedsQL 4.0 Generic Core Scale is a validated questionnaire that measures health-related quality of life in children and adolescents. Participants will complete the age-appropriate version of the PedsQL. It includes 23 items across four subscales: physical, emotional, social, and school functioning. Responses are reverse-scored and transformed to a 0-100 scale. Higher scores indicate better quality of life. The change in total score from baseline to follow-up time points will be assessed.

    Time frame: Baseline (Day 0), Week 3 (after the 3rd Shiatsu session), Week 6 (after the 6th Shiatsu session, end of intervention), and Week 18 (3 months post-intervention)

Secondary outcomes

  1. Change in Pediatric Quality of Life Inventory Family Impact Module (PedsQL FIM) Total Score

    The Pediatric Quality of Life Inventory Family Impact Module (PedsQL FIM) is a validated caregiver-reported questionnaire that assesses the impact of a child's health condition on family functioning. It includes 36 items covering physical, emotional, social, and cognitive functioning, communication, worry, daily activities, and family relationships. Responses are reverse-scored and transformed to a 0-100 scale. Higher scores indicate better family functioning and less caregiver burden. The change in total score from baseline to follow-up time points will be assessed.

    Time frame: Baseline (Day 0), Week 3 (after the 3rd Shiatsu session), Week 6 (after the 6th Shiatsu session, end of intervention), and Week 18 (3 months post-intervention)

  2. Change in Pain Intensity (Numerical Rating Scale, NRS)

    Pain intensity will be self-reported using the Numerical Rating Scale (NRS), a validated 11-point scale ranging from 0 to 10, where 0 means "no pain" and 10 means "worst possible pain." Participants will rate their pain at each time point. The change in score from baseline to follow-up time points will be assessed.

    Time frame: Baseline (Day 0), Week 3 (after the 3rd Shiatsu session), Week 6 (after the 6th Shiatsu session, end of intervention), and Week 18 (3 months post-intervention)

07

Study locations

1 of 2 sites recruiting
  • Tel Aviv Univrsity
    Tel Aviv, Tel Aviv, Israel
    Not yet recruiting
  • Dana-Dwek Children's Hospital, Tel Aviv Sourasky Medical Center
    Tel Aviv, 64239-06, Israel
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — The research team has not yet finalized a plan for sharing individual participant data (IPD). Data sharing options will be considered in accordance with institutional board review, policies, ethical guidelines in our institution, ethical guidelines for pediatric research, and data privacy regulations.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Sep 2028, 40 months after the start.

Of 1,295 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 40 months is above that.

Counting every sponsor, half of 1,378 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

Since we started tracking on Sep 25, 2026, the dates moved once, on Sep 29, 2026: primary completion Apr 2027 → Sep 2028 and completion Apr 2027 → Sep 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 1, 2025
First posted
Apr 16, 2025
StartActual
May 1, 2025
Primary completionEst.
Sep 30, 2028was Apr 2027
CompletionEst.
Sep 30, 2028was Apr 2027
Last update
Sep 29, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Apr 30, 2027→Sep 30, 2028
Sep 29, 2026
Study completion
Apr 30, 2027→Sep 30, 2028
Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    Primary completion Apr 30, 2027→Sep 30, 2028
    Study completion Apr 30, 2027→Sep 30, 2028
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06929598
Collaborators
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, Dana-Dwek Children's Hospital
Responsible party
Eyal Cohen-Sela (Medical Doctor, Tel Aviv University) — Principal investigator
First posted
Apr 16, 2025
Start date
May 1, 2025
Primary completion
Sep 30, 2028 (estimated)
Completion
Sep 30, 2028 (estimated)
Last update
Sep 29, 2026

Study contacts

Eyal Cohen-Sela, MD
Contact
cohensela@mail.tau.ac.il
+972-3-6974247
Merav Heshin-Bekenstein, MD
Contact
prheum@tlvmc.gov.il
+972-3-6974247
Merav Heshin-Bekenstein, MD
principal investigator · Dana Dwek Children's Hospital, Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion